BSEM
BioStem Technologies, Inc. Common Stock
Nasdaq · usd
BioStem Technologies, Inc. Common Stock (BSEM) trades at $1.54 (-1.91%) as of 4:10:04 PM EDT on Oct 26, 2026, -62.80% over the past month. Market cap is $29.32M, with 1.0 days to cover in short interest.
Stock performance
How BioStem Technologies, Inc. Common Stock (BSEM) stock has performed from one day to one year, with its 52-week range.
- 1D
- -1.91%
- 1W
- +0.00%
- 1M
- -62.80%
- YTD
- -59.58%
- 1Y
- -67.23%
- 52-wk range
- $1.40 – $8.40
Key statistics
Today's trading snapshot for BSEM: day range, open, previous close, volume and market cap.
- Day range
- $1.40 – $1.61
- Open
- $1.57
- Prev close
- $1.57
- Volume
- 169.11K
- Market cap
- $29.32M
- Shares out
- 18.67M
8-K filings
Material corporate events BioStem Technologies, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Regulatory decisionSep 30, 2026
BioTissue received such clearance in June 2026
- Private placementSep 18, 2026
The Company entered into a common stock purchase agreement with Roth Principal Investments under which the Company may, in its sole discretion, sell up to $40,000,000 of shares of Common Stock. The Purchase Shares will be issued without registration under the Securities Act, in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D as sales to an accredited investor.
- Listing transferAug 7, 2026
BioStem Technologies, Inc. announced that its shares of common stock have been approved by The Nasdaq Stock Market LLC for listing on The Nasdaq Capital Market. Trading in the Company's common stock transitioned from the OTCID Basic Market to Nasdaq effective as of the opening of trading on August 7, 2026, and now trades on Nasdaq under its current ticker symbol 'BSEM.'
Dividend history and stock splits
BioStem Technologies, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-400Jan 27, 2015
BSEM short interest
How heavily BSEM is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 98.45K
- Avg volume
- 226.04K
As of · reported to FINRA twice monthly.
BSEM news
The latest news and headlines about BioStem Technologies, Inc. Common Stock (BSEM).
- BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and PremierpositiveGlobeNewswire Inc.· Sep 4, 2026
- BioStem Technologies Announces Nasdaq UplistingpositiveGlobeNewswire Inc.· Aug 6, 2026
- BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare ConferencepositiveGlobeNewswire Inc.· Feb 20, 2026
- BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings' Surgical and Wound Care BusinesspositiveBenzinga· Jan 21, 2026
- BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care ConferencepositiveGlobeNewswire Inc.· Dec 10, 2025
Frequently asked questions
What is the BioStem Technologies, Inc. Common Stock (BSEM) stock price today?
BioStem Technologies, Inc. Common Stock (BSEM) is trading at $1.54 (-1.91% on the day) as of 4:10:04 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is BioStem Technologies, Inc. Common Stock?
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases.
What is the short interest in BSEM?
As of Sep 30, 2026, BSEM has 98.45K shares short and 1.0 days to cover.
What exchange is BSEM listed on?
BioStem Technologies, Inc. Common Stock (BSEM) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of BSEM with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BSEM analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.